Ultrasis (ULT)
market vs.
industry GROWTH & VALUE
| Trailing 12m | ||||
| PE Ratio (ttm) | n/a |
|
|
|
| PEG Ratio (ttm) |
|
|
||
| EPS Growth (ttm) | % |
|
|
|
| Dividend Yield (ttm) | % |
|
|
|
| Valuation (ttm) | ||||
| Price to Book Value | 1.46 |
|
|
|
| Price to Tang. Book |
|
|
||
| Price to Free Cashflow |
|
|
||
| Price to Sales |
|
|
||
| EV to EBITDA |
|
|
||
market vs.
industry QUALITY
| Year End 31st Jul | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | TTM | 2013E | 2014E | CAGR / Avg | |
| Revenue | £m | ||||||||||
| Operating Profit | £m | ||||||||||
| Net Profit | £m | ||||||||||
| EPS Reported | p | ||||||||||
| EPS Normalised | p | ||||||||||
| EPS Growth | % | ||||||||||
| PE Ratio | x | ||||||||||
| PEG | x | ||||||||||
| Profitability | |||||||||||
| Operating Margin | % | ||||||||||
| ROA | % | ||||||||||
| ROCE | % | ||||||||||
| ROE | % | ||||||||||
| Cashflow | |||||||||||
| Op. Cashflow ps | p | ||||||||||
| Capex ps | p | ||||||||||
| Free Cashflow ps | p | ||||||||||
| Dividends | |||||||||||
| Dividend ps | p | ||||||||||
| Dividend Growth | % | ||||||||||
| Dividend Yield | % | ||||||||||
| Dividend Cover | x | ||||||||||
| Balance Sheet | |||||||||||
| Cash etc | £m | ||||||||||
| Working Capital | £m | ||||||||||
| Net Fixed Assets | £m | ||||||||||
| Net Debt | £m | ||||||||||
| Book Value | £m | ||||||||||
| Average Shares | m | ||||||||||
| Book Value ps | p | +5.2% | |||||||||
FINANCIAL BRIEF: For the fiscal year ended 31 July 2012, Ultrasis plc revenues decreased 62% to L1.1M. Net loss increased from L50K to L3.4M. Revenues reflect Rest of World segment decrease of 83% to L203K, United Kingdom segment decrease of 48% to L866K. Higher net loss reflects United Kingdom segment loss totaling L1.1M vs. income of L123K, Rest of World segment loss increase from L97K to L307K. more »
| Leverage (ttm) | Total | Ex Intang | |||
| Gross Gearing | % | ||||
| Net Gearing | % | ||||
| Cash / Assets | % | ||||
| Liquidity (ttm) | ||
| Current Ratio | ||
| Quick Ratio | ||
| Interest Cover | ||
| Efficiency (ttm) | ||
| Asset Turnover | ||
| Rec's Turnover | ||
| Stock Turnover | ||
market vs.
industry RECENT HISTORY
| Latest interim period (ended 31st Jan '13) vs. prior year | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| 3yr Average Annualised | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| DPS Growth | % |
|
|
|
BROKER CONSENSUS & FORECAST TREND
| Recommendation: | Strong Sell | Sell | Hold | Buy | Strong Buy |
|---|---|---|---|---|---|
| No. of Analysts: |
Ultrasis plc is a United Kingdom-based holding company. The activities of the Company’s subsidiaries include providing interactive healthcare products and services for the improvement of health, wellbeing and personal performance. It provides health, psychology, software development and program management services. It delivers healthcare products to the consumer, the national health service, the corporate sector and other healthcare providers in the United Kingdom and the United States. Its products include Beating the Blues, GetFit Wellness, My Brain Solutions, The Relief Series, Drink and Drug Wise and Tension Taker. Beating the Blues is a computerised program of cognitive behavioral therapy. GetFit Wellness services provide health promotion and health management programs. The Relief Series is a range of self-help, online multimedia programs offering education and awareness to help promote mental health and well-being. Tension Taker is the latest in bio-feedback technology.
Directors: Nigel Brabbins (CEO) , John Smith (Exec. Dir.) , Charlie Martin (Exec. Dir.) , Penelope Tembra (Secy.) ,
No. of Employees: 28 No. of Shareholders: n/a
| Last Annual | July 31st, 2012 |
| Last Interim | January 31st, 2013 |
| Shares in Issue | 1,522,569,811 |
| Free Float | 1.05bn (69.0%) |
| Sector | Healthcare |
| Industry | Healthcare Providers & Services |
| Index | FTSE Aim All Share, |
| Exchange |
London Stock Exchange (AIM) |
| Eligible for | an ISA? a SIPP? |
| Address | 5th Floor Winchester House,259-269 Old Marylebone Road, LONDON, NW1 5RA, United Kingdom |
| Web | http://www.ultrasis.com |
| Phone | +44 20 75352050 |
| Contact | Nigel Brabbins (CEO) |
| Registrar | Capita Registrars Limited (Huddersfield) |
| Auditors | Nexia Smith & Williamson |
| Tue 7:00am | Strategic partnership with US Joint Venture |
| 1st May | Issue of Equity and Block listing update |
| 2nd Apr | Change of Adviser |
| 20th Mar | Interim Results |
| 4th Feb | Issue of Shares under Share Incentive Plan |
| 30th Jan | Result of AGM |
